284 related articles for article (PubMed ID: 23336348)
21. Thrombolysis Guided by Perfusion Imaging up to 9 Hours after Onset of Stroke.
Ma H; Campbell BCV; Parsons MW; Churilov L; Levi CR; Hsu C; Kleinig TJ; Wijeratne T; Curtze S; Dewey HM; Miteff F; Tsai CH; Lee JT; Phan TG; Mahant N; Sun MC; Krause M; Sturm J; Grimley R; Chen CH; Hu CJ; Wong AA; Field D; Sun Y; Barber PA; Sabet A; Jannes J; Jeng JS; Clissold B; Markus R; Lin CH; Lien LM; Bladin CF; Christensen S; Yassi N; Sharma G; Bivard A; Desmond PM; Yan B; Mitchell PJ; Thijs V; Carey L; Meretoja A; Davis SM; Donnan GA;
N Engl J Med; 2019 May; 380(19):1795-1803. PubMed ID: 31067369
[TBL] [Abstract][Full Text] [Related]
22. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.
Ciccone A; Valvassori L; Nichelatti M;
Int J Stroke; 2011 Jun; 6(3):259-65. PubMed ID: 21557814
[TBL] [Abstract][Full Text] [Related]
23. Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.
Clark WM; Wissman S; Albers GW; Jhamandas JH; Madden KP; Hamilton S
JAMA; 1999 Dec; 282(21):2019-26. PubMed ID: 10591384
[TBL] [Abstract][Full Text] [Related]
24. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
25. Wake-up stroke within 3 hours of symptom awareness: imaging and clinical features compared to standard recombinant tissue plasminogen activator treated stroke.
Roveri L; La Gioia S; Ghidinelli C; Anzalone N; De Filippis C; Comi G
J Stroke Cerebrovasc Dis; 2013 Aug; 22(6):703-8. PubMed ID: 22133742
[TBL] [Abstract][Full Text] [Related]
26. Early ischemic change on CT versus diffusion-weighted imaging for patients with stroke receiving intravenous recombinant tissue-type plasminogen activator therapy: stroke acute management with urgent risk-factor assessment and improvement (SAMURAI) rt-PA registry.
Nezu T; Koga M; Nakagawara J; Shiokawa Y; Yamagami H; Furui E; Kimura K; Hasegawa Y; Okada Y; Okuda S; Kario K; Naganuma M; Maeda K; Minematsu K; Toyoda K
Stroke; 2011 Aug; 42(8):2196-200. PubMed ID: 21719764
[TBL] [Abstract][Full Text] [Related]
27. Pretreatment blood-brain barrier damage and post-treatment intracranial hemorrhage in patients receiving intravenous tissue-type plasminogen activator.
Leigh R; Jen SS; Hillis AE; Krakauer JW; Barker PB;
Stroke; 2014 Jul; 45(7):2030-5. PubMed ID: 24876245
[TBL] [Abstract][Full Text] [Related]
28. Prediction of Early Arterial Recanalization and Tissue Fate in the Selection of Patients With the Greatest Potential to Benefit From Intravenous Tissue-Type Plasminogen Activator.
Leiva-Salinas C; Patrie JT; Xin W; Michel P; Jovin T; Wintermark M
Stroke; 2016 Feb; 47(2):397-403. PubMed ID: 26696647
[TBL] [Abstract][Full Text] [Related]
29. Association of Clinical, Imaging, and Thrombus Characteristics With Recanalization of Visible Intracranial Occlusion in Patients With Acute Ischemic Stroke.
Menon BK; Al-Ajlan FS; Najm M; Puig J; Castellanos M; Dowlatshahi D; Calleja A; Sohn SI; Ahn SH; Poppe A; Mikulik R; Asdaghi N; Field TS; Jin A; Asil T; Boulanger JM; Smith EE; Coutts SB; Barber PA; Bal S; Subramanian S; Mishra S; Trivedi A; Dey S; Eesa M; Sajobi T; Goyal M; Hill MD; Demchuk AM;
JAMA; 2018 Sep; 320(10):1017-1026. PubMed ID: 30208455
[TBL] [Abstract][Full Text] [Related]
30. The Efficacy of IV Tissue Plasminogen Activator for Restoring Cerebral Blood Flow in the Hours Immediately after Administration in Patients with Acute Stroke.
Majidi S; Simpkins AN; Leigh R;
J Neuroimaging; 2019 Mar; 29(2):206-210. PubMed ID: 30508260
[TBL] [Abstract][Full Text] [Related]
31. Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?
Shaltoni HM; Albright KC; Gonzales NR; Weir RU; Khaja AM; Sugg RM; Campbell MS; Cacayorin ED; Grotta JC; Noser EA
Stroke; 2007 Jan; 38(1):80-4. PubMed ID: 17122433
[TBL] [Abstract][Full Text] [Related]
32. Magnetic Resonance Imaging-DRAGON score: 3-month outcome prediction after intravenous thrombolysis for anterior circulation stroke.
Turc G; Apoil M; Naggara O; Calvet D; Lamy C; Tataru AM; Méder JF; Mas JL; Baron JC; Oppenheim C; Touzé E
Stroke; 2013 May; 44(5):1323-8. PubMed ID: 23482603
[TBL] [Abstract][Full Text] [Related]
33. Two tales: hemorrhagic transformation but not parenchymal hemorrhage after thrombolysis is related to severity and duration of ischemia: MRI study of acute stroke patients treated with intravenous tissue plasminogen activator within 6 hours.
Thomalla G; Sobesky J; Köhrmann M; Fiebach JB; Fiehler J; Zaro Weber O; Kruetzelmann A; Kucinski T; Rosenkranz M; Röther J; Schellinger PD
Stroke; 2007 Feb; 38(2):313-8. PubMed ID: 17204683
[TBL] [Abstract][Full Text] [Related]
34. Usefulness of triphasic perfusion computed tomography for intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke.
Lee KH; Lee SJ; Cho SJ; Na DG; Byun HS; Kim YB; Song HJ; Jin IS; Chung CS
Arch Neurol; 2000 Jul; 57(7):1000-8. PubMed ID: 10891982
[TBL] [Abstract][Full Text] [Related]
35. Early and continuous neurologic improvements after intravenous thrombolysis are strong predictors of favorable long-term outcomes in acute ischemic stroke.
Yeo LL; Paliwal P; Teoh HL; Seet RC; Chan BP; Wakerley B; Liang S; Rathakrishnan R; Chong VF; Ting EY; Sharma VK
J Stroke Cerebrovasc Dis; 2013 Nov; 22(8):e590-6. PubMed ID: 23954601
[TBL] [Abstract][Full Text] [Related]
36. Tenecteplase-tissue-type plasminogen activator evaluation for minor ischemic stroke with proven occlusion.
Coutts SB; Dubuc V; Mandzia J; Kenney C; Demchuk AM; Smith EE; Subramaniam S; Goyal M; Patil S; Menon BK; Barber PA; Dowlatshahi D; Field T; Asdaghi N; Camden MC; Hill MD;
Stroke; 2015 Mar; 46(3):769-74. PubMed ID: 25677596
[TBL] [Abstract][Full Text] [Related]
37. Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.
Furlan A; Higashida R; Wechsler L; Gent M; Rowley H; Kase C; Pessin M; Ahuja A; Callahan F; Clark WM; Silver F; Rivera F
JAMA; 1999 Dec; 282(21):2003-11. PubMed ID: 10591382
[TBL] [Abstract][Full Text] [Related]
38. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke.
Parsons M; Spratt N; Bivard A; Campbell B; Chung K; Miteff F; O'Brien B; Bladin C; McElduff P; Allen C; Bateman G; Donnan G; Davis S; Levi C
N Engl J Med; 2012 Mar; 366(12):1099-107. PubMed ID: 22435369
[TBL] [Abstract][Full Text] [Related]
39. Relationship between magnetic resonance angiography-diffusion-weighted imaging mismatch and clinical outcome in endovascular treatment for acute ischemic stroke: subgroup analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism--Japan Registry.
Deguchi I; Dembo T; Yoshimura S; Sakai N; Okada Y; Kitagawa K; Kimura K; Hyogo T; Yamagami H; Egashira Y; Tanahashi N
J Stroke Cerebrovasc Dis; 2014 Jul; 23(6):1471-6. PubMed ID: 24685994
[TBL] [Abstract][Full Text] [Related]
40. Intra-arterial adjuvant tirofiban after unsuccessful intra-arterial thrombolysis of acute ischemic stroke: preliminary experience in 16 patients.
Kwon JH; Shin SH; Weon YC; Hwang JC; Baik SK
Neuroradiology; 2011 Oct; 53(10):779-85. PubMed ID: 21808986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
